Raiffeisen Bank International AG Increases Stock Position in Kenvue Inc. $KVUE

Raiffeisen Bank International AG raised its stake in shares of Kenvue Inc. (NYSE:KVUE) by 75.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,372 shares of the company’s stock after purchasing an additional 26,810 shares during the quarter. Raiffeisen Bank International AG’s holdings in Kenvue were worth $1,019,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Allianz Asset Management GmbH lifted its holdings in shares of Kenvue by 57.6% during the 2nd quarter. Allianz Asset Management GmbH now owns 45,368 shares of the company’s stock worth $950,000 after acquiring an additional 16,580 shares during the last quarter. AlTi Global Inc. bought a new stake in Kenvue during the second quarter worth about $219,000. Sumitomo Mitsui Trust Group Inc. lifted its stake in Kenvue by 1.7% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,861,654 shares of the company’s stock worth $101,754,000 after purchasing an additional 79,724 shares during the last quarter. AlphaQuest LLC boosted its holdings in shares of Kenvue by 276.0% in the 2nd quarter. AlphaQuest LLC now owns 12,086 shares of the company’s stock worth $253,000 after purchasing an additional 8,872 shares in the last quarter. Finally, AG2R LA Mondiale Gestion D Actifs increased its position in shares of Kenvue by 4.7% during the 2nd quarter. AG2R LA Mondiale Gestion D Actifs now owns 75,683 shares of the company’s stock valued at $1,584,000 after purchasing an additional 3,427 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on KVUE shares. Edward Jones cut Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Evercore set a $18.00 price target on shares of Kenvue in a research note on Tuesday, October 28th. Canaccord Genuity Group boosted their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and reduced their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Finally, Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Four equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus price target of $20.08.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The shares were bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.17% of the stock is owned by insiders.

Kenvue Stock Up 0.3%

Shares of Kenvue stock opened at $18.73 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company’s 50 day moving average price is $17.54 and its 200-day moving average price is $17.59. The stock has a market capitalization of $35.88 billion, a price-to-earnings ratio of 24.32, a P/E/G ratio of 4.29 and a beta of 0.59.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.86%. The firm’s revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date is Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.